0000000000815621

AUTHOR

R. Strauss

showing 2 related works from this author

Visual motion integration controls attractiveness of objects in walking flies and a mobile robot

2008

Walking fruit flies are attracted by near-by objects. They estimate the distance to these objects by the parallax motion of their images on the retina. Here we provide evidence from robot simulations that distance is assessed by motion integration over large parts of the visual field and time periods of 0.5 s to 2 s. The process in flies is not selective to image motion created by the self-motion of the fly but also sensitive to object motion and to the pattern contrast of objects. Added visual motion (e.g. oscillations) makes objects more attractive than their stationary counterparts. Front-to-back motion, the natural parallax motion on the eyes of a forward-translating fly, is preferred. …

Retinabusiness.industryComputer scienceOrientation (computer vision)media_common.quotation_subjectMobile robotMotion (physics)Visual fieldmedicine.anatomical_structureMotion estimationComputer graphics (images)medicineRobotContrast (vision)Computer visionArtificial intelligencebusinessParallaxmedia_common2008 IEEE/RSJ International Conference on Intelligent Robots and Systems
researchProduct

Effects of Ribavirin Dose Reduction vs Erythropoietin for Boceprevir-Related Anemia in Patients With Chronic Hepatitis C Virus Genotype 1 Infection—A…

2013

International audience; Background & AimsTreatment of hepatitis C virus (HCV) infection with boceprevir, peginterferon, and ribavirin can lead to anemia, which has been managed by reducing ribavirin dose and/or erythropoietin therapy. We assessed the effects of these anemia management strategies on rates of sustained virologic response (SVR) and safety.MethodsPatients (n = 687) received 4 weeks of peginterferon and ribavirin followed by 24 or 44 weeks of boceprevir (800 mg, 3 times each day) plus peginterferon and ribavirin. Patients who became anemic (levels of hemoglobin approximately ≤10 g/dL) during the study treatment period (n = 500) were assigned to groups that were managed by ribavi…

Maleviruses[SDV]Life Sciences [q-bio]Hepacivirusmedicine.disease_causeGastroenterologyPolyethylene Glycolslaw.inventionchemistry.chemical_compound0302 clinical medicineRandomized controlled triallawErythropoiesisIncidenceGastroenterologyDisease Managementvirus diseasesAnemiaMiddle AgedRecombinant Proteins3. Good healthTreatment Outcome030220 oncology & carcinogenesisDrug Therapy CombinationFemale030211 gastroenterology & hepatologyAlgorithmsmedicine.drugmedicine.medical_specialtyGenotypeProlineSide effectAnemiaHepatitis C virusInterferon alpha-2Antiviral Agents03 medical and health sciencesInternal medicineBoceprevirRibavirinmedicineHumansErythropoietinDAADose-Response Relationship DrugHepatologybusiness.industryRibavirinInterferon-alphaHepatitis C Chronicbiochemical phenomena metabolism and nutritionmedicine.diseasedigestive system diseasesSide EffectLogistic ModelschemistryErythropoietinImmunologyHemoglobinbusinessEPO
researchProduct